Healthcare Resource Consumption and Cost of Invasive Meningococcal Disease in France: A Study of the National Health Insurance Database-Reference-Cited by-同舟云学术

Healthcare Resource Consumption and Cost of Invasive Meningococcal Disease in France: A Study of the National Health Insurance Database

Published:2021-06-25 Issue:3 Volume:10 Page:1607-1623
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Weil-Olivier Catherine^ORCID,Taha Muhamed-Kheir^ORCID,Emery Corinne^ORCID,Bouée Stéphane^ORCID,Beck Ekkehard^ORCID,Aris Emmanuel^ORCID,Loncle-Provot Véronique^ORCID,Nachbaur Gaëlle^ORCID,Pribil Céline^ORCID

Funder

GlaxoSmithKline Biologicals SA

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40121-021-00468-w.pdf

Reference33 articles.

1. Acevedo R, Bai X, Borrow R, et al. The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations. Expert Rev Vaccines. 2019;18:15–30.

2. Harrison LH, Pelton SI, Wilder-Smith A, et al. The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease. Vaccine. 2011;29:3363–71.

3. Whittaker R, Dias JG, Ramliden M, et al. The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004–2014. Vaccine. 2017;35:2034–41.

4. Feldman C, Anderson R. Meningococcal pneumonia: a review. Pneumonia (Nathan). 2019;11:3.

5. Sall O, Stenmark B, Glimaker M, et al. Clinical presentation of invasive disease caused by Neisseria meningitidis serogroup Y in Sweden, 1995 to 2012. Epidemiol Infect. 2017;145:2137–43.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. THE ECONOMIC BURDEN OF INVASIVE FORMS OF MENINGOCOCCAL INFECTION;2024-06-27

2. Recent increase in atypical presentations of invasive meningococcal disease in France;BMC Infectious Diseases;2024-06-26

3. Public Health Impact and Cost-Effectiveness Analysis of 4-Component Meningococcal Serotype B Vaccination for Infants in France;PharmacoEconomics - Open;2024-05-23

4. A Reduction in the Number of Hospitalized Cases of Acute Meningitis during the COVID-19 Pandemic in Japan;Internal Medicine;2024-05-15

5. Invasive meningococcal disease in older adults: current perspectives and call for action;European Geriatric Medicine;2024-05-06